|
|
 |
 |
 |
Rapid Pharma Development Team
 |
Dr. Robert Hett
Managing Partner
Founder of RPD
Education:
Chemist RWTH-Aachen
Postdoc University of Notre Dame
Key experience:
Business Development, Process Chemistry, API Development, GMP, CRO Management, CMC Project Management, Audits, 6 Patents, 15 Publications, Board member of OPRD
Previous Experience:
| Carbogen: |
|
Site Manager, of a pilot plant of 80 people, API custom manufacturing for early phase development under c-GMP
|
| Sepracor: |
|
Senior Research Chemist
|
|
 |
Dr. Dieter Krimmer
Managing Partner
Founder of RPD
Education:
Chemist, TH Stuttgart
Key experience:
Project Management, Fermentation, Chemical and Formulation Development, Drug Product, Regulatory Experience (FDA, EMEA, Bfarm), Validation, Qualification, Audits and Inspections
Previous Experience:
| Independent Consultant: |
|
CMC Management for e.g. Gilead, Trigen
|
| Hofmann La Roche: |
|
Technical Team Leader for the products INVIRASE®, VIRACEPT®, TAMIFLU®
|
|
 |
Dr. Cees Winnips
Freelance Consultant for RPD
Education:
Physician, University of Amsterdam
Key experience:
21 years in pharmaceutical industry: Clinical Research Phase I-IV, Pulmonary Drug Delivery, Business Development & Finance, Marketing, Founding & Management of Start-up companies, Strong negotiation skills.
Previous Experience:
| Lumavita AG: |
|
Chief Scientific Officer, Founder of Necura which became Shogoo and later Lumavita AG, a specialized infective disease company
|
| Wyeth AG: |
|
Medical Advisor transplantation, oncology and infective disease
|
| WHO: |
|
Advisor to global malaria program
|
| SkyePharma: |
|
Vice President Pulmonary Drug Delivery unit
|
| Ciba/Novartis: |
|
Medical Advisor Oncology, Women's health, Cardiovascular. Marketing
Manager Ciba Austria, International Product Manager Asthma & COPD
|
|
 |
Dr. Helmut Buschmann
Freelance Consultant for RPD
Education:
Chemist, RWTH Aachen
Key experience:
Preclinical Pharma Development, Medicinal Chemistry, Generation and Evaluation of intellectual Property, 200 patents, 95 publications, 3 books Advanced 15+ NCEs into the clinical phase (e.g. Rosonabant, Cizorlitine, Dulopetine, Axomadol). Some have reached clinical phase III or are marketed (e.g. Tapentadol, Nucynta® Palexia®).
Previous Experience:
| Esteve: |
|
Research Director, preclinical research activities and intellectual property managed 100 people
|
| Grünenthal: |
|
Head of Chemical Research, medicinal chemistry, process development and pilot plant, managed a total staff of 90 people
|
|
 |
Hayno Rustige Dipl. Ing.
Freelance Consultant for RPD
Education:
Master of Mechanical Engineering,
TU München / TH Stuttgart
Key experience:
Design and implementation of new corporate Quality Management Systems according to GMP, qualifications and validations, preparation of and participation in inspections, more than 40 patents.
Previous Experience:
| RPD GmbH: |
|
freelance consultant since 2008
|
| Micronisierungskontor GmbH: |
|
Quality Assurance Manager (commissarial) since 2005
|
| logic DATA GmbH: |
|
Managing Director
|
| Veit Bügeltechnik GmbH & Co: |
|
Head of development (managed 35 employees)
|
| Haru präzision GmbH, Stuttgart: |
|
Head of Quality Assurance & Managing Director (managed 40 employees)
|
| Robert Bosch GmbH, Stuttgart: |
|
Development and Test Engineer (hydraulic systems)
|
|
|
|
 |